Veracyte Inc. VCYT
$51.23
▼ -0.19% 24H
About
Veracyte Inc. is a global diagnostics company specializing in advanced genomic tests that provide clinicians with precise insights to diagnose and treat cancer. Its portfolio features key products such as Afirma for thyroid cancer, Decipher Prostate and Decipher Bladder for prostate and bladder cancers respectively, Pr…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees755
TickerVCYT
Statistics
Market Cap$4.09B
Revenue (TTM)$517.1M
Net Income$66.4M
Net Margin12.8%
EPS$0.82
P/E43.91
P/S6.98
P/B2.87
EV/EBITDA33.05
ROE6.9%
Dividend Yield—
Price$51.23
Data: Twelve Data · Revenue = mcap / P/S